Mitzlaff, K., Kirstein, M., Müller, C., Venerito, M., Olkus, A., Dill, M.T., Weinmann, A., Kocheise, L., Busch, A., Schulze, K., Allo, G., Waldschmidt, D.-T., Barsch, M., Bengsch, B., Quante, M., González-Carmona, M. Á., Himmelsbach, V., Finkelmeier, F., Klöckner, R.T., Schirmacher, P., Marquardt, J. und Zimpel, C. (2024) Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: a multicenter real world cohort [cd]. Freiburg: Universität. doi:10.1002/ueg2.12656.

Mitzlaff, Katharina, Martha Kirstein, Christian Müller, Marino Venerito, Alexander Olkus, Michael T. Dill, Arndt Weinmann, Lorenz Kocheise, Alina Busch, Kornelius Schulze, Gabriel Allo, Dirk-Thomas Waldschmidt, Maryam Barsch, Bertram Bengsch, Michael Quante, María Á. González-Carmona, Vera Himmelsbach, Fabian Finkelmeier, Roman Trutz Klöckner, Peter Schirmacher, Jens U Marquardt, und Carolin Zimpel. Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: a multicenter real world cohort. Cd. Freiburg: Universität, [2024?], Freiburg: Universität, [2024?]. https://doi.org/10.1002/ueg2.12656.

Mitzlaff, K., Kirstein, M., Müller, C., Venerito, M., Olkus, A., Dill, M. T., Weinmann, A., Kocheise, L., Busch, A., Schulze, K., Allo, G., Waldschmidt, D.-T., Barsch, M., Bengsch, B., Quante, M., González-Carmona, M. Á., Himmelsbach, V., Finkelmeier, F., Klöckner, R. T., Schirmacher, P., Marquardt, J., & Zimpel, C. (ca. 2024). Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: a multicenter real world cohort [Cd]. Universität. https://doi.org/10.1002/ueg2.12656

Mitzlaff, K., M. Kirstein, C. Müller, M. Venerito, A. Olkus, M. T. Dill, A. Weinmann, L. Kocheise, A. Busch, K. Schulze, G. Allo, D.-T. Waldschmidt, M. Barsch, B. Bengsch, M. Quante, M. Á. González-Carmona, V. Himmelsbach, F. Finkelmeier, R. T. Klöckner, P. Schirmacher, J. Marquardt, und C. Zimpel. Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: a multicenter real world cohort. cd, Universität, 2024, https://doi.org/10.1002/ueg2.12656.

MITZLAFF, Katharina, Martha KIRSTEIN, Christian MÜLLER, Marino VENERITO, Alexander OLKUS, Michael T. DILL, Arndt WEINMANN, Lorenz KOCHEISE, Alina BUSCH, Kornelius SCHULZE, Gabriel ALLO, Dirk-Thomas WALDSCHMIDT, Maryam BARSCH, Bertram BENGSCH, Michael QUANTE, María Á. GONZÁLEZ-CARMONA, Vera HIMMELSBACH, Fabian FINKELMEIER, Roman Trutz KLÖCKNER, Peter SCHIRMACHER, Jens U MARQUARDT und Carolin ZIMPEL, 2024. Efficacy, safety and differential outcomes of immune‐chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: a multicenter real world cohort. Freiburg: Universität